NR4A1 and breast carcinoma: The Luminal A subtype, known for its hormone receptor positivity, low Ki-67 proliferative index and better prognosis, suggests that it presents a distinct profile that may be more directly affected by prenatal hormonal environments compared to other breast cancer subtypes.